PRC1 plays an important role in lung adenocarcinoma and is potentially targeted by fostamatinib.
Zhu P, Cui N, Song ZY, Yong WX, Luo XX, Wang GC, Wang X, Wu YN, Xu Q, Zhang LM, Hao GX, Liu Y, Zhang ZM.
Zhu P, et al.
Eur Rev Med Pharmacol Sci. 2022 Dec;26(23):8924-8934. doi: 10.26355/eurrev_202212_30567.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 36524512
Free article.